KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Other Non-Current Liabilities (2016 - 2025)

Idexx Laboratories has reported Other Non-Current Liabilities over the past 17 years, most recently at $56.5 million for Q4 2025.

  • Quarterly results put Other Non-Current Liabilities at $56.5 million for Q4 2025, up 27.48% from a year ago — trailing twelve months through Dec 2025 was $56.5 million (up 27.48% YoY), and the annual figure for FY2025 was $56.5 million, up 27.48%.
  • Other Non-Current Liabilities for Q4 2025 was $56.5 million at Idexx Laboratories, down from $57.6 million in the prior quarter.
  • Over the last five years, Other Non-Current Liabilities for IDXX hit a ceiling of $85.0 million in Q2 2021 and a floor of $44.3 million in Q4 2024.
  • Median Other Non-Current Liabilities over the past 5 years was $65.9 million (2023), compared with a mean of $65.0 million.
  • Biggest five-year swings in Other Non-Current Liabilities: tumbled 32.33% in 2024 and later grew 27.48% in 2025.
  • Idexx Laboratories' Other Non-Current Liabilities stood at $70.9 million in 2021, then decreased by 4.73% to $67.6 million in 2022, then decreased by 3.05% to $65.5 million in 2023, then tumbled by 32.33% to $44.3 million in 2024, then grew by 27.48% to $56.5 million in 2025.
  • The last three reported values for Other Non-Current Liabilities were $56.5 million (Q4 2025), $57.6 million (Q3 2025), and $56.8 million (Q2 2025) per Business Quant data.